Lazard Asset Management’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,261
| Closed | -$93K | – | 2533 |
|
|
2024
Q4 | $93K | Buy |
6,261
+6,078
| +3,321% | +$90.3K | ﹤0.01% | 1822 |
|
|
2024
Q3 | $2K | Sell |
183
-5,679
| -97% | -$62.1K | ﹤0.01% | 2096 |
|
|
2024
Q2 | $89K | Buy |
+5,862
| New | +$89K | ﹤0.01% | 1785 |
|
|
2023
Q4 | – | Sell |
-3,960
| Closed | -$71K | – | 2441 |
|
|
2023
Q3 | $71K | Buy |
+3,960
| New | +$71K | ﹤0.01% | 1755 |
|
|
2023
Q1 | – | Sell |
-6,415
| Closed | -$132K | – | 2508 |
|
|
2022
Q4 | $132K | Hold |
6,415
| – | – | ﹤0.01% | 1420 |
|
|
2022
Q3 | $167K | Buy |
6,415
+3,979
| +163% | +$104K | ﹤0.01% | 1312 |
|
|
2022
Q2 | $61K | Hold |
2,436
| – | – | ﹤0.01% | 1724 |
|
|
2022
Q1 | $76K | Buy |
+2,436
| New | +$76K | ﹤0.01% | 1524 |
|
|
2021
Q1 | – | Sell |
-2,645
| Closed | -$68K | – | 1989 |
|
|
2020
Q4 | $68K | Buy |
+2,645
| New | +$68K | ﹤0.01% | 1292 |
|